Impact of DSP4-induced locus coeruleus dysfunction on sleep: Systematic review and methodology.
Impact of DSP4-induced locus coeruleus dysfunction on sleep: Systematic review and methodology.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
DK · Author affiliation · country only
Center of Functionally Integrative Neuroscience, Department of Clinical Medicine, Aarhus University, Denmark. Electronic address: west@cfin.au.dk.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
Sleep and brain health are closely coupled, yet the mechanisms underlying this relationship remain incompletely understood. The locus coeruleus (LC) is a key modulator of sleep architecture, and LC dysfunction (LCd) is implicated in a wide range of neurodegenerative and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, depression, and post-traumatic stress disorder. The isolated effects of LCd on sleep and brain health cannot be studied in humans, but they can be modeled in animals using the noradrenergic neurotoxin DSP4, which produces chronic and selective LC degeneration. Here, we provide a systematic review of the impact of DSP4-based LC ablation on sleep. We summarize the substantial (and often under-reported) variability in DSP4 outcomes and place these findings in the broader context of LC physiology and pathology. We then review DSP4's mechanism of action and identify methodological and biological factors likely contributing to the pronounced inter-study variability. Finally, we offer practical considerations to support more consistent DSP4-based LC ablation, enabling robust investigation of the consequences of chronic LCd for sleep architecture and overall brain health.